Jake Bauer's Net Worth
$7.6 Million
Who is Jake Bauer?
Jake Bauer has an estimated net worth of $7.6 Million. This is based on reported shares across multiple companies, which include ARYA Sciences Acquisition Corp V, ARYA Sciences Acquisition Corp II, MyoKardia Inc, and Enliven Therapeutics, Inc..
SEC CIK
Jake Bauer's CIK is 0001654909
Past Insider Trading and Trends
2018 was Jake Bauer's most active year for acquiring shares with 10 total transactions. Jake Bauer's most active month to acquire stocks was the month of January. 2018 was Jake Bauer's most active year for disposing of shares, totalling 19 transactions. Jake Bauer's most active month to dispose stocks was the month of December. 2019 saw Jake Bauer paying a total of $423,931.26 for 116,300 shares, this is the most they've acquired in one year. In 2019 Jake Bauer cashed out on 99,043 shares for a total of $3,920,381.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARYA Sciences Acquisition Corp V No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYA Sciences Acquisition Corp II (CERE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MyoKardia Inc No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -90.21K |
—
|
—
|
0
|
Nov 17
| |||
Form 4
| +0.51% | 293 |
$50.41 | $14,771.16 | 57.78K |
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +15.08% | 7.53K |
$34.98 | -$153,700.41 | 57.49K |
Jan 3 - Jan 6
| |||
Form 4
| +14.63% | 6.38K |
—
|
—
| 49.96K |
Jan 1
| |||
Form 4
| -3.15% | -1.42K |
$40.61 | -$1,130,371.42 | 43.58K |
Scheduled
|
Dec 20
| ||
Form 4
| -32.06% | -21.23K |
$65.31 | -$1,386,687.25 | 45K |
Scheduled
|
Nov 27 - Nov 29
| ||
Form 4
| +0.25% | 162 |
$40.07 | $6,491.18 | 66.23K |
Oct 31
| |||
Form 4
|
—
|
0
|
$35.37 | -$974,151.94 | 66.07K |
Scheduled
|
Sep 20
| ||
Form 4
| +0.48% | 313 |
$40.78 | $12,765.08 | 66.07K |
Apr 30
| |||
Form 4/A
|
—
|
0
|
$27.57 | -$153,215.77 | 66.78K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| -0.93% | -570.00 |
$42.98 | -$24,496.09 | 60.76K |
Jan 7
| |||
Form 4
| +2.38% | 1.43K |
—
|
—
| 61.33K |
Jan 1
| |||
Form 4
| -1.16% | -706.00 |
$48.81 | -$42,762.58 | 59.9K |
Scheduled
|
Oct 31 - Nov 2
| ||
Form 4
|
—
|
0
|
$35.39 | -$322,314.69 | 60.61K |
Scheduled
|
Jul 23
| ||
Form 4
| -1.90% | -1.17K |
$41.05 | -$62,818.85 | 60.61K |
Scheduled
|
Apr 30 - May 3
| ||
Form 4
|
—
|
0
|
$31.13 | -$188,750.00 | 61.78K |
Scheduled
|
Apr 11
| ||
Form 4
|
—
|
0
|
$30.02 | -$6,866.68 | 61.78K |
Scheduled
|
Mar 26
| ||
Form 4
|
—
|
0
|
$34.54 | -$259,793.84 | 61.78K |
Scheduled
|
Feb 26
| ||
Form 4/A
|
—
|
0
|
$28.63 | -$163,750.00 | 61.78K |
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
| -8.09% | -5.00K |
$45.00 | -$225,000.00 | 56.78K |
Scheduled
|
Jan 9
| ||
Form 4
| -7.49% | -5.00K |
$42.89 | -$214,465.77 | 61.78K |
Scheduled
|
Jan 2
| ||
Form 4
| +1.88% | 1.23K |
$11.56 | $14,241.92 | 66.78K |
Oct 31
| |||
Form 4
| -18.62% | -15.00K |
$28.33 | -$425,000.00 | 65.55K |
Scheduled
|
Aug 7
| ||
Form 4
| -5.10% | -4.33K |
$15.02 | -$65,059.99 | 80.55K |
Scheduled
|
Jul 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
| +1.17% | 978 |
$11.09 | $10,848.47 | 84.88K |
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| -0.79% | -667.00 |
$15.00 | -$10,005.00 | 83.9K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +1.83% | 1.52K |
$10.03 | $15,235.57 | 84.57K |
Oct 31 - Nov 1
| |||
Form 4
| +1.73% | 1.42K |
$8.50 | $12,036.00 | 83.05K |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $21.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 87.37K |
—
|
—
| 87.37K |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||